The Online Investor
Biotechnology M&A image Biotechnology M&A » By The Online Investor Staff, updated Mon., Aug. 8, 1:31 PM Recent mergers and acquisitions in the Biotechnology M&A category.

Slide #66. Illumina, Inc. Verinata Health

Acquirer: Illumina, Inc. (NASDAQ:ILMN)
Acquiree: Verinata Health
Details: Illumina, Inc. (NASDAQ:ILMN) today announced it has completed its previously announced acquisition of Verinata Health, Inc., a leading provider of non-invasive tests for the early identification of fetal chromosomal abnormalities. As of the close, Verinata Health became a wholly owned subsidiary of Illumina.

Illumina is engaged in sequencing- and array-based solutions for genetic and genomic analysis. Co. provides whole-genome sequencing, genotyping, noninvasive prenatal testing (NIPT), and product support services. Using Co.'s services, customers can perform whole-genome sequencing projects and microarray projects (including large-scale genotyping studies and whole-genome association studies). Co. provides NIPT services through its partner laboratories that direct samples to Co. on a test send-out basis in its Clinical Laboratory Improvements Amendments-certified, College of Pathologists-accredited laboratory. Co. also provides support services to customers who have purchased its products.

ILMN SEC Filing Email Alerts Service

Open the ILMN Page at The Online Investor »

Company Name: 
Illumina Inc
Stock buyback: 
ILMN buyback
Number of ETFs Holding ILMN: 
Total Market Value Held by ETFs: 
Total Market Capitalization: 
% of Market Cap. Held by ETFs: 

Open the ILMN Page at The Online Investor (in a new window) »

Quotes delayed 20 minutes

Email EnvelopeFree ILMN Email Alerts:
Get SEC Filing Alerts
Get Dividend Alerts

Hold (2.44 out of 4)
0th percentile
(ranked lower than approx. 100% of all stocks covered)

Analysts' Target Price:
ILMN Stock Forecast

Based on Zacks ABR data;
powered by Xignite

Biotechnology M&A - Slide 66 of 83 Page |

Copyright © 1998 - 2022, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.